Supplementary table II(a-c)

Published: 27 September 2022| Version 1 | DOI: 10.17632/9v46888y3v.1
Contributor:

Description

Concomitant immunomodulating therapy during treatment.

Files

Institutions

Universiteit van Amsterdam

Categories

Safety, Ethnicity, Race, Systemic Treatment, Atopic Dermatitis, Methotrexate, Skin Type

Licence